Revolune Announces Commercial Availability of Multiplex Immunofluorescence Reagents
Company enters commercialization phase following successful early access program and appoints Adrian Arechiga as Chief Commercial Officer OBERKOCHEN, Germany, June 15, 2026 /PRNewswire/ -- Revolune today announced the commercial availability of its multiplex immunofluorescence reagent...
Company enters commercialization phase following successful early access program and appoints Adrian Arechiga as Chief Commercial Officer OBERKOCHEN, Germany, June 15, 2026 /PRNewswire/ -- Revolune today announced the commercial availability of its multiplex immunofluorescence reagent...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.